MY ACCOUNT | NEWSLETTER |

Clinicopathologic, GI effects of prednisone with probiotics to dogs


The effect of administering of probiotics or twice-daily omeprazole on glucocorticoid-induced gastric bleeding in dogs is unknown. The aim of this double-blinded, placebo-controlled randomized trial was to compare gastrointestinal bleeding among dogs administered placebo, prednisone (2 mg/kg q24h), prednisone with omeprazole (1 mg/kg q12h), or prednisone with probiotics (Visbiome, 11.2-22.5 billion CFU/kg q24h) for 28 days.

Clinical signs and endoscopic gastrointestinal mucosal lesion scores of 24 healthy research dogs at baseline (t1), day 14 (t2), and day 28 (t3) were compared using split-plot repeated-measures mixed-model ANOVAs.

Data showed that fecal score differed by treatment-by-time (F [6,40] = 2.65, P < .03), with higher scores in groups receiving prednisone at t3 than t1. Nineteen of thirty-three episodes of diarrhea occurred in the prednisone with omeprazole group.

Gastric mucosal lesion scores differed by treatment-by-time (F [6,60] = 2.86, P = .05), among treatment groups (F [3,60] = 4.9, P = .004), and over time (F [2,60] = 16.5, P < .001).

Post hoc analysis revealed lesion scores increased over time for all groups receiving prednisone. At t3, scores for the prednisone (8.7 ± 4.9) and prednisone with probiotics (8.7 ± 4.9) groups differed significantly from placebo (1.8 ± 1.8; P ≤ .04), whereas scores for the prednisone with omeprazole (6.5 ± 5.5) group did not differ from placebo (P = .7). Ulcers occurred only in dogs receiving prednisone.

The authors concluded that prednisone-induced gastric bleeding. Co-administration of omeprazole partially mitigated bleeding, but a similar protective benefit was not demonstrated by co-administration of the evaluated probiotic.

Mariola B Rak et al. “Clinicopathologic and gastrointestinal effects of administration of prednisone, prednisone with omeprazole, or prednisone with probiotics to dogs: A double-blind randomized trial.” J Vet Intern Med. 2023 Mar;37(2):465-475. doi: 10.1111/jvim.16672.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity

Like0
Dislike0

Canine and Human Dirofilariosis in the Rostov Region (Southern Russia)

Like0
Dislike0

Infrared thermography: Current applications in equine medicine

Like0
Dislike0

Deadly pathogens found in commercial raw cat foods

Like0
Dislike0

Famous Online, Delicious IRL: Woof Gang Launches Iconic Dog Treat Collab

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top